>"These factors are slowing the interest in transgenic animals as a production alternative (...) as protein purification is generally easier from serum-protein free cell cuture media than from milk" (...) "the benefic of trangenics is in cost-of-goods, the ability to scale up by breeding animals instead of building bioreactors (...)<
This is a comment that applies almost specifically to monoclonal antibodies. For any other protein, milk has the starting advantage.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.